Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-06

Clinical Trial Update: Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL [Phase 3]

View source ↗

Summary

A multicenter pediatric Phase 3 study evaluating pharmacokinetics and safety of EXPAREL has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Postoperative Pain Management | Phase 3 | Status: COMPLETED | Results posted: 2021-01-06